Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Regulatory News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Clinigen Group plc

30 Dec 2021 16:36

RNS Number : 1015X
BNP Paribas London
30 December 2021
 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1.

KEY INFORMATION

 

 (a) Full name of discloser:

 

BNP Paribas SA

 (b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

 (c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Clinigen Group plc

 (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

 (e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

29/12/2021

 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No:

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a)

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

0.1p ordinary (GB00B89J2419)

 

 

 

Interests

 

Short Positions

 

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,327,482

1.00

-153,390

-.12

(2) Cash-settled derivatives:

 

152,503

.11

-1,327,425

-1.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

TOTAL:

1,479,985

1.11

-1,480,815

-1.11

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b)

Rights to subscribe for new securities (including directors'' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)

Purchases and sales

 

Class of relevant

security

Purchase/sale

Number of

securities

Price per unit

GB00B89J2419

Purchase

7,111

9.2050 GBP

GB00B89J2419

Purchase

72

9.2050 GBP

 

(b)

Cash-settled derivative transactions

 

Class of

relevant

security

Product

description

e.g. CFD

Nature of dealing

e.g. opening/closing a

long/short position

increasing/reducing a

long/short position

Number of

references

securities

Price per

unit

GB00B89J2419

Contract for Difference

Reducing a Short Position

-7,111

9.1779 GBP

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class

of

relevant

security

Product

description

e.g. call

option

Writing,

purchasing,

selling,

varying etc.

Number

of

securities

to which

option

relates

Exercise

price

per unit

Type

e.g.

American

European

etc.

Expiry

date

Option

money

paid/

received

per unit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)

Exercise

 

Class of

relevant

security

Product

description

e.g. call option

Exercising/

exercised

against

Number of

securities

Exercise price

per unit

 

 

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

Class of relevant

security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if

applicable)

 

 

 

 

 

 

 

 

 

4.

Other Information

 

(a)

Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

(b)

Indemnity and other dealing arrangements

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

(c)

Attachments

 

Is a supplemental Form 8 (Open Positions) attached?

 

No

 

 

Date of Disclosure:

 

30/12/2021

Contact Name

 

Compliance Control Room

Telephone Number:

 

0207 595 9695

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETFZMFZVGKGMZM
Date   Source Headline
4th Apr 20224:54 pmRNSForm 8.5 (EPT/RI)-Clinigen Group plc_Amend
4th Apr 20223:29 pmRNSForm 8.3 - [Clinigen Group plc/Triley Bidco Ltd]
4th Apr 20223:20 pmRNSForm 8.3 - Clinigen Group plc
4th Apr 20223:20 pmRNSForm 8.3 - Clinigen Group plc
4th Apr 202212:31 pmGNWForm 8.3 - Clinigen Group PLC
4th Apr 202211:46 amGNWForm 8.3 - AXA INVESTMENT MANAGERS: Clinigen Group Plc
4th Apr 202211:09 amRNSForm 8.5 (EPT/RI)- Clinigen Group plc
4th Apr 202210:59 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Clinigen Group PLC
4th Apr 202210:50 amRNSScheme Becomes Effective
4th Apr 20229:50 amRNSForm 8.5 (EPT/NON-RI) Clinigen Group plc
4th Apr 20229:19 amRNSForm 8.5 (EPT/RI) - Clinigen Group Plc
4th Apr 20227:30 amRNSSuspension - Clinigen Group PLC
1st Apr 20223:29 pmRNSForm 8.3 - Clinigen Group plc
1st Apr 20223:25 pmRNSForm 8.3 - Clinigen Group
1st Apr 20223:20 pmRNSForm 8.3 - Clinigen Group plc
1st Apr 20223:00 pmRNSForm 8.3 - Clinigen Group plc
1st Apr 20221:27 pmGNWForm 8.3 - Clinigen Group PLC
1st Apr 20221:09 pmRNSForm 8.5 (EPT/RI)-Clinigen Group plc
1st Apr 202210:59 amRNSForm 8.5 (EPT/NON-RI)-CLINIGEN GROUP PLC
1st Apr 202210:52 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Clinigen Group PLC
1st Apr 202210:22 amRNSForm 8.5 (EPT/RI) - Clinigen Group PLC
1st Apr 20229:56 amRNSForm 8.3 - Clinigen Group Plc
31st Mar 20225:52 pmRNSForm 8.5 (EPT/RI)- Clinigen Group plc Amend
31st Mar 20223:30 pmGNWForm 8.3 - Clinigen Group plc
31st Mar 20223:29 pmRNSForm 8.3 - Clinigen Group plc
31st Mar 20223:27 pmRNSForm 8.3 - Clinigen Group plc
31st Mar 20223:20 pmRNSForm 8.3 - Clinigen Group plc
31st Mar 202212:54 pmRNSCourt Sanction of Scheme of Arrangement
31st Mar 202212:52 pmGNWForm 8.3 - Clinigen Group PLC
31st Mar 202211:11 amRNSForm 8.3 - CLINIGEN GROUP PLC
31st Mar 202211:09 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Clinigen Group PLC
31st Mar 202210:48 amRNSForm 8.5 (EPT/RI)- Clinigen Group plc
31st Mar 202210:41 amRNSForm 8.5 (EPT/NON-RI) Clinigen Group plc
31st Mar 202210:10 amRNSForm 8.3 - Clinigen Group Plc
30th Mar 20225:30 pmRNSClinigen Group
30th Mar 20223:21 pmRNSForm 8.3 - Clinigen Group Plc
30th Mar 20223:20 pmRNSForm 8.3 - Clinigen Group plc
30th Mar 20222:42 pmRNSForm 8.3 - Clinigen Group Plc
30th Mar 20221:44 pmGNWForm 8.3 - Clinigen Group PLC
30th Mar 202211:45 amRNSForm 8.5 (EPT/NON-RI)- Clinigen Group plc
30th Mar 202211:37 amRNSForm 8.5 (EPT/RI)- Clinigen Group plc
30th Mar 202211:19 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Clinigen Group PLC
30th Mar 202210:49 amRNSForm 8.3 - Clinigen Group PLC
30th Mar 202210:35 amRNSForm 8.5 (EPT/NON-RI) Clinigen Group plc
30th Mar 202210:34 amRNSForm 8.3 - Clinigen Group Plc
29th Mar 20223:20 pmRNSForm 8.3 - Clinigen Group plc
29th Mar 20222:48 pmRNSForm 8.3 - Clinigen Group Plc
29th Mar 20222:43 pmRNSForm 8.3 -Clinigen Group plc
29th Mar 20221:30 pmBUSForm 8.3 - CLINIGEN GROUP PLC
29th Mar 202212:55 pmGNWForm 8.3 - Clinigen Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.